| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.53B | 40.94B | 41.31B | 37.18B | 23.84B | 18.08B |
| Gross Profit | 20.61B | 21.29B | 19.81B | 17.72B | 16.18B | 14.63B |
| EBITDA | 8.06B | 7.54B | 7.14B | 6.16B | 5.47B | 4.53B |
| Net Income | 4.98B | 5.19B | 4.05B | 3.47B | 2.95B | 2.31B |
Balance Sheet | ||||||
| Total Assets | 913.94B | 919.96B | 849.69B | 822.84B | 819.92B | 827.82B |
| Cash, Cash Equivalents and Short-Term Investments | 80.17B | 77.75B | 149.64B | 151.75B | 122.75B | 152.67B |
| Total Debt | 99.42B | 105.37B | 96.25B | 93.03B | 91.67B | 92.01B |
| Total Liabilities | 859.27B | 865.37B | 798.40B | 772.49B | 769.91B | 775.18B |
| Stockholders Equity | 54.23B | 54.12B | 50.89B | 49.96B | 49.67B | 52.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -27.59B | -21.90B | -6.84B | 13.24B | 10.88B |
| Operating Cash Flow | 0.00 | -27.26B | -20.49B | -5.56B | 15.18B | 12.22B |
| Investing Cash Flow | 0.00 | -18.32B | 11.45B | 15.81B | -22.58B | -8.99B |
| Financing Cash Flow | 0.00 | -6.15B | -6.63B | 587.00M | -772.00M | 265.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £208.06B | 13.49 | 8.88% | 4.27% | -11.86% | -24.31% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £55.67B | 10.47 | 8.08% | 3.41% | -22.85% | -21.12% | |
65 Neutral | £35.94B | 11.02 | 9.85% | 1.70% | -4.35% | 21.86% | |
65 Neutral | £27.46B | 9.78 | 25.01% | 1.56% | 37.94% | 291.37% | |
64 Neutral | £43.30B | 9.00 | 14.96% | 3.85% | 4.27% | 26.21% | |
61 Neutral | £54.16B | 9.37 | 9.41% | 1.50% | 14.18% | 46.12% |